Early neutrophil-to-lymphocyte ratio reduction as a surrogate marker of prognosis in never smokers with advanced lung adenocarcinoma receiving gefitinib or standard chemotherapy as first-line therapy

被引：0
|
作者：
Youngjoo Lee
Sun Hye Kim
Ji-Youn Han
Heung Tae Kim
Tak Yun
Jin Soo Lee
机构：
[1] National Cancer Center,Center for Lung Cancer
[2] National Cancer Center,Center for Clinical Trials
来源：
Journal of Cancer Research and Clinical Oncology | 2012年 / 138卷
关键词：
Adenocarcinoma; Gefitinib; Lymphocyte; Neutrophil; Non-small-cell lung cancer; Prognostic marker; Predictive marker;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2009 / 2016
页数：7
相关论文
共 50 条
  • [1] Early neutrophil-to-lymphocyte ratio reduction as a surrogate marker of prognosis in never smokers with advanced lung adenocarcinoma receiving gefitinib or standard chemotherapy as first-line therapy
    Lee, Youngjoo
    Kim, Sun Hye
    Han, Ji-Youn
    Kim, Heung Tae
    Yun, Tak
    Lee, Jin Soo
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2012, 138 (12) : 2009 - 2016
  • [2] Circulating cell-free DNA in plasma of never smokers with advanced lung adenocarcinoma receiving gefitinib or standard chemotherapy as a first-line therapy
    Lee, Young Joo
    Yoon, Kyong-Ah
    Lee, Jin Soo
    [J]. CANCER RESEARCH, 2011, 71
  • [3] Circulating Cell-Free DNA in Plasma of Never Smokers with Advanced Lung Adenocarcinoma Receiving Gefitinib or Standard Chemotherapy as First-Line Therapy
    Lee, Young Joo
    Yoon, Kyong-Ah
    Han, Ji-Youn
    Kim, Heung Tae
    Yun, Tak
    Lee, Geon Kook
    Kim, Hyae Young
    Lee, Jin Soo
    [J]. CLINICAL CANCER RESEARCH, 2011, 17 (15) : 5179 - 5187
  • [4] Gefitinib as a first-line therapy of advanced or metastatic adenocarcinoma of the lung in never-smokers
    Lee, D
    Han, J
    Lee, E
    Kim, H
    Kim, H
    Hong, E
    Lee, J
    [J]. LUNG CANCER, 2005, 49 : S38 - S38
  • [5] Gefitinib as a first-line therapy of advanced or metastatic adenocarcinoma of the lung in never-smokers
    Lee, DH
    Han, JY
    Lee, HG
    Lee, JJ
    Lee, EK
    Kim, HY
    Kim, HK
    Hong, EK
    Lee, JS
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (08) : 3032 - 3037
  • [6] NEUTROPHIL-TO-LYMPHOCYTE RATIO REDUCTION AS A SURROGATE MARKER OF PROGNOSIS IN PATIENTS WITH METASTATIC CLEAR CELL RENAL CELL CARCINOMA RECEIVING SUNITINIB AS FIRST-LINE THERAPY
    Park, Yong Hyun
    Lee, Young Ju
    Ku, Ja Hyeon
    Kwak, Cheol
    Kim, Hyeon Hoe
    [J]. JOURNAL OF UROLOGY, 2013, 189 (04): : E787 - E787
  • [7] Elevation of neutrophil-to-lymphocyte ratio before first-line chemotherapy predicts a poor prognosis of second line chemotherapy in gastric cancer
    Inoue, D.
    Nakazono, A.
    Hatao, F.
    Imamura, K.
    Namiki, S.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [8] Elevated neutrophil-to-lymphocyte ratio predicts poor outcome in patients with advanced non-small-cell lung cancer receiving first-line gefitinib or erlotinib treatment
    Lin, Gui-Nan
    Peng, Jie-Wen
    Liu, Pan-Pan
    Liu, Dong-Ying
    Xiao, Jian-jun
    Chen, Xiao-Qin
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 (05) : E189 - E194
  • [9] Elevation of Neutrophil-to-Lymphocyte Ratio before First-Line Chemotherapy Predicts a Poor Prognosis for Second-Line Chemotherapy in Gastric Cancer
    Inoue, Dai
    Sekiguchi, Shuhei
    Yamagata, Wataru
    Maeda, Gen
    Yamada, Daiki
    Fujiwara, Shun
    Itou, Shiori
    Kurihara, Masamichi
    Hijioka, Yuko
    Shimoji, Kohei
    Fujiki, Junko
    Nakazono, Ayano
    Horike, Hideyuki
    Yoshioka, Atsushi
    Ogura, Yuki
    Hatao, Fumihiko
    Imamura, Kazuhiro
    Namiki, Shin
    [J]. ONCOLOGY, 2019, 96 (03) : 140 - 146
  • [10] A randomized phase III study of gefitinib (IRESSATM) versus standard chemotherapy (gemcitabine plus cisplatin) as a first-line treatment for never-smokers with advanced or metastatic adenocarcinoma of the lung
    Lee, Jin S.
    Park, Keunchil
    Kim, Sang-We
    Lee, Dae Ho
    Kim, Heung Tae
    Han, Ji-Youn
    Yun, Tak
    Ahn, Myung-Ju
    Ahn, Jin Seok
    Suh, Cheolwon
    Lee, Jung-Shin
    Han, Jong Hee
    Yu, Sun Young
    Lee, Jae Won
    Jo, SookJung
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S283 - S284
12345